First-in-human study of the toxicity, pharmacokinetics, and pharmacodynamics of CG200745, a pan-HDAC inhibitor, in patients with refractory solid malignancies.
- DOI
- 10.1007/s10637-015-0262-2
- Published
- 2015 Oct
- Container
- Investigational new drugs
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10637-015-0262-2,
title = {First-in-human study of the toxicity, pharmacokinetics, and pharmacodynamics of CG200745, a pan-HDAC inhibitor, in patients with refractory solid malignancies.},
author = {Kim KP and Park SJ and Kim JE and Hong YS and Lee JL and Bae KS and Cha H and Kwon SK and Ro S and Cho J and Kim TW},
year = {2015},
journal = {Investigational new drugs},
doi = {10.1007/s10637-015-0262-2},
url = {https://doi.org/10.1007/s10637-015-0262-2}
}RIS
TY - JOUR TI - First-in-human study of the toxicity, pharmacokinetics, and pharmacodynamics of CG200745, a pan-HDAC inhibitor, in patients with refractory solid malignancies. AU - Kim KP AU - Park SJ AU - Kim JE AU - Hong YS AU - Lee JL AU - Bae KS AU - Cha H AU - Kwon SK AU - Ro S AU - Cho J AU - Kim TW PY - 2015 JO - Investigational new drugs DO - 10.1007/s10637-015-0262-2 UR - https://doi.org/10.1007/s10637-015-0262-2 ER -
APA
KP, K., SJ, P., JE, K., YS, H., JL, L., KS, B., H, C., SK, K., S, R., J, C., & TW, K. (2015). First-in-human study of the toxicity, pharmacokinetics, and pharmacodynamics of CG200745, a pan-HDAC inhibitor, in patients with refractory solid malignancies.. Investigational new drugs. https://doi.org/10.1007/s10637-015-0262-2
Source records
- pubmed · retrieved 2026-09-26T19:40:27.903Z